Company Profile
Updated: 17-SEP-09Advanced Research Press Inc.
Private Company, Headquarters Location
690 Rte. 25A, Ste. 150, Setauket, NY 11733, United States
(800)653-1151, (631)751-9696, (631)751-9696 fax, http://www.fitnessrxmag.com
Primary SIC: Miscellaneous Publishing, Primary NAICS: Database and Directory Publishers
Description: Miscellaneous Publishing
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Ligand's JAK3 Research Collaboration Extended by Pfizer.
Blood Weekly; 11/19/2009; 1329 words; ...3.1 million in research payments to continue...to extend the JAK3 research collaboration with...companies in a number of research collaborations...programs are based on advanced cell-based assays...be found in prior press releases available...Ligand Pharmaceuticals Inc., Marketing ...
Study data from University of Kansas update understanding of epilepsy.(Report)
Biotech Week; 11/18/2009; 699 words; ...also less likely than PWOE to report advanced educational attainment, and more...colleagues published the results of their research in Epilepsy & Behavior (Health behaviors...Behavior can be contacted at: Academic Press Inc. Elsevier Science, 525 B St...
Endocyte presents data on EC145 in treatment of ovarian cancer at the 16th annual meeting of the European Society of Gynaecologic Oncology.
Cancer Weekly; 11/17/2009; 1504 words; Endocyte, Inc., a cancer...treatment for advanced ovarian cancer...the Purdue Research Park of West...Endocyte's advanced proprietary...2a trials in advanced ovarian and...NCT00722592 This press release contains...Endocyte Inc., (765...Clinical Trial Research, ...
Bombardier's CSeries Aircraft Wing Manufacturing Facility Gets Under Way in Belfast.
Marketwire Canada; 11/17/2009; 1369 words; ...available on the Canadian Press picture wire and EPA...for the production of advanced composite aircraft wings...Resin Transfer Infusion advanced composites process...currently engaged in the research and development of the...services, Bombardier Inc. is a global corporation...
Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting.
PR Newswire; 11/16/2009; 931 words; ...Oncolytics Biotech Inc. (TSX:ONC, NASDAQ...for patients with advanced cancers will be presented...in Patients with Advanced Solid Cancers With...Oncolytics Biotech Inc. Oncolytics is a...oncolyticsbiotech.com/. This press release contains...the success of its research and development ...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning